Last reviewed · How we verify

NCT06135519: MSCs

Dermogenesis With Mesenchymal Stem Cells

Completed NA Last updated 7 March 2024
What this trial tests

NA trial testing Autologous Mesenchymal stem cells injection in Dermal Regeneration in 20 participants. Completed in 22 February 2024.

Timeline
23 July 2023
Primary endpoint
22 February 2024
22 February 2024

Quick facts

Lead sponsorKing Edward Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date23 July 2023
Primary completion22 February 2024
Estimated completion22 February 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

King Edward Medical University

Who can join

Under 50, any sex, with Dermal Regeneration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dermogenesis With Mesenchymal Stem Cells in treating Post Acne Depressed Spots

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Mesenchymal stem cells in injury repair of vital organs: from mechanism to clinical application.
    Bao L, Wang Z, Li L, Tang S, et al · · 2025 · cited 1× · PMID 40686745 · DOI 10.62347/ygxa7976
  2. Adipose Tissue-Derived Stem Cells Enhance Dermogenesis of Post-Acne Depressed Spots.
    Bashir A, Choudhery MS, Afzaal S, Ali S, et al · · 2025 · PMID 41078325 · DOI 10.1111/jocd.70399

Verify or expand the search:

Other King Edward Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06135519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing